Corcept Therapeutics

This study tested a new drug combination (relacorilant plus nab-paclitaxel) in 178 women with ovarian, fallopian tube, or peritoneal cancer that came back after platinum-based treatment. The goal was to see if the combo could delay cancer growth better than nab-paclitaxel alone. …

This study tested a drug called relacorilant in 137 people with high cortisol levels due to non-cancerous adrenal gland growths. The goal was to see if the drug could improve blood pressure and blood sugar control. Participants received either the drug or a placebo, and researche…

This study looked at over 1,100 adults in the US with resistant hypertension (high blood pressure that doesn't respond well to treatment) to find out how many also have a condition called endogenous hypercortisolism, where the body makes too much cortisol. Participants provided b…

This study looked at how well two different tablet forms of the drug miricorilant are absorbed by the body. It involved 18 healthy adults who took the drug in different forms and had their blood levels measured. The goal was to compare the formulations, not to treat any disease.